TcLand Expression appoints two
New chairman and vp of marketing and commercial operations
The French pioneer in the development of gene expression biomarkers for unmet needs in transplantation and auto-immune disease, has also appointed Patrick Terry as chairman of the Board. Terry, a Board member since 2009, succeeds TcLand Expression ceo Alain Huriez, who had held the position since 2005.
Terry is co-founder of Genomic Health and a founder of the Personalised Medicine Coalition.
You may also like
Research & Development
Naobios, Nuvonis and the European Vaccine Initiative collaborate to manufacture influenza challenge agent
Working with the Inno4Vac consortium, Naobios will leverage Nuvonis’s Vero Cell Bank to support the development of a controlled human infection model based on the influenza virus A(H3N2)
Research & Development
Wegovy cuts risk of heart attack, stroke or death by 57% compared with tirzepatide
Study adds to growing evidence suggesting that the heart-protective benefits seen with Wegovy are specific to the semaglutide molecule and therefore cannot be extended to other GLP-1 or GIP/GLP-1-based treatments
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Hamilton Health Sciences chosen for BirchBioMed burn scar treatment trial
BirchBioMed announces Hamilton Health Sciences’ (HHS) Centre for Burn Research in Ontario as the first contracted clinical trial site for its Phase II/III randomised study of the naturally based compound: FS2.
Research & Development
Indena and TCG GreenChem join forces to advance next-generation ADC technologies
Indena and TCG GreenChem are pleased to announce a new strategic collaboration aimed at accelerating the development of innovative and market-ready payload-linkers: the key component of antibody-drug conjugates (ADCs)